Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Novel Inhibitory Effect of Naloxone on Macrophage.

Slides:



Advertisements
Similar presentations
Date of download: 5/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: RVX-208: A Small Molecule That Increases Apolipoprotein.
Advertisements

Date of download: 5/27/2016 Copyright © 2016 SPIE. All rights reserved. E0771 breast cancer cells do not produce nor respond to TNF-α. (a): In vitro TNF-α.
Date of download: 5/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Persistent Activation of Nuclear Factor Kappa-B.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pro-Osteogenic Phenotype of Human Aortic Valve Interstitial.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Renal Denervation in Moderate Treatment-Resistant.
Date of download: 5/30/2016 Copyright © The American College of Cardiology. All rights reserved. From: Noninvasive Quantification and Optimization of Acute.
Date of download: 5/31/2016 Copyright © The American College of Cardiology. All rights reserved. From: High-Dose Atorvastatin Reduces Periodontal Inflammation:
Date of download: 5/31/2016 Copyright © The American College of Cardiology. All rights reserved. From: Phosphorylcholine-Targeting Immunization Reduces.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Relationship Between Vascular Endothelial Growth.
Date of download: 6/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Treatment of Neural Anosmia by Topical Application.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Oxidized Phospholipids Are Present on Plasminogen,
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Mycophenolate Mofetil Decreases Atherosclerotic Lesion.
Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Different Effects of a High-Cholesterol Diet on Ischemic.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Lipid Profile, Plasma Apolipoproteins, and Risk of.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: SOCS1 Prevents Graft Arteriosclerosis by Preserving.
Date of download: 6/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: High Telomerase Activity in Neutrophils From Unstable.
Date of download: 6/20/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pregnancy-Associated Plasma Protein-A Is Markedly.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Novel Collagen Matricryptin Reduces Left Ventricular.
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: EUK-8, a Superoxide Dismutase and Catalase Mimetic,
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Homocysteine Modulates the CD40/CD40L System J Am.
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Genetic Inhibition of CETP, Ischemic Vascular Disease.
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Inhibition of Vascular Oxidative Stress in Hypercholesterolemia.
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Molecular Imaging of Matrix Metalloproteinase in.
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: An Endocrine Genetic Signal Between Blood Cells.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Irbesartan, an angiotensin type 1 receptor inhibitor,
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of MF-tricyclic, a selective cyclooxygenase-2.
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Plasma triglycerides and type III hyperlipidemia.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Reduction in Hemoglobin–Oxygen Affinity Results.
Date of download: 6/28/2016 Copyright © 2016 American Society of Anesthesiologists. All rights reserved. Increased interleukin (IL)-10 release induced.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Proposal to Incorporate Trial Data Into a Hybrid.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Peroxynitrite decomposition catalysts prevent myocardial.
Date of download: 7/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Oxidation-Specific Biomarkers, Prospective 15-Year.
Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: Sustained Release of Erythropoietin Using Biodegradable.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: 10-Year Coronary Heart Disease Risk Prediction Using.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: A combination of oral endothelin-areceptor antagonist.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Angiotensin-converting enzyme inhibition reduces.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Comparative effects of AT1-antagonism and angiotensin-converting.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Atherothrombosis J Am Coll Cardiol. 2012;60(10):
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Modified Serum Profiles of Inflammatory and Vasoconstrictive.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pulmonary Vein Total Occlusion Following Catheter.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Inflammation in Atherosclerosis: From Pathophysiology.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: CD40 Ligand+ Microparticles From Human Atherosclerotic.
Date of download: 7/11/2016 Copyright © The American College of Cardiology. All rights reserved. From: Movement of the Esophagus During Left Atrial Catheter.
Date of download: 7/14/2016 Copyright © The American College of Cardiology. All rights reserved. From: TCTAP C-172 Successful Endovascular Treatment for.
Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship between tumor necrosis factor-alpha.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Peroxisome Proliferator-Activated Receptor-γ.
From: High-Density Lipoprotein Cholesterol and Particle Concentrations, Carotid Atherosclerosis, and Coronary Events: MESA (Multi-Ethnic Study of Atherosclerosis)
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: An endogenous inhibitor of nitric oxide synthase.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Implications of Coronary Artery Calcium Testing.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of Bariatric Surgery on Human Small Artery.
Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Exenatide Reduces Infarct Size and Improves Cardiac.
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Increased transforming growth factor-beta1 circulating.
Copyright © 2005 American Medical Association. All rights reserved.
Omega-6 polyunsaturated fatty acids prevent atherosclerosis development in LDLr-KO mice, in spite of displaying a pro-inflammatory profile similar to.
Volume 147, Issue 4, Pages (April 2015)
Arterioscler Thromb Vasc Biol
Natural killer T cells accelerate atherogenesis in mice
Volume 43, Issue 6, Pages (December 2015)
Volume 69, Issue 8, Pages (April 2006)
Controlled release of ascorbic acid from gelatin hydrogel attenuates abdominal aortic aneurysm formation in rat experimental abdominal aortic aneurysm.
Volume 15, Issue 3, Pages (March 2012)
Thomas E. Arnold, MD, Dmitri Gnatenko, PhD, Wadie F. Bahou, MD 
Volume 124, Issue 3, Pages (March 2003)
Volume 14, Issue 10, Pages (March 2016)
Yunmei Wang, Huiyun Gao, Candace M
Volume 10, Issue 1, Pages (July 2009)
Volume 15, Issue 3, Pages (March 2012)
Erratum to “Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out mice” [Int J Cardiol 139.
Volume 85, Issue 1, Pages (January 2014)
Presentation transcript:

Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Novel Inhibitory Effect of Naloxone on Macrophage Activation and Atherosclerosis Formation in Mice J Am Coll Cardiol. 2006;48(9): doi: /j.jacc Effect of naloxone treatment on the lipopolysaccharide (LPS)-induced macrophage release of tumor necrosis factor-α (TNF-α) (A), interleukin (IL)-6 (B), and monocyte chemoattractant protein (MCP)-1 (C). Human acute monocytic leukemia cell (THP-1) culture was pretreated for 1 h with the indicated concentrations of naloxone before stimulation with 100 ng/ml LPS. Supernatants were harvested at 24 h for the measurement of TNF-α, IL-6, and MCP-1. The results are expressed as mean values ± SD of 3 experiments. *p < 0.05 compared with the LPS-treated cultures. PBS = phosphate-buffered saline. Figure Legend:

Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Novel Inhibitory Effect of Naloxone on Macrophage Activation and Atherosclerosis Formation in Mice J Am Coll Cardiol. 2006;48(9): doi: /j.jacc Effect of naloxone treatment on oxidized low-density lipoprotein (oxLDL)-induced macrophage release of TNF-α (A), IL-6 (B), and MCP-1 (C). The THP-1 cell culture was pretreated for 1 h with the indicated concentrations of naloxone before stimulation with 10 μg/ml oxLDL. Supernatants were harvested at 24 h for the measurement of TNF-α, IL-6, and MCP-1. The results are expressed as mean values ± SD of 3 experiments. *p < 0.05 compared with the oxLDL-treated cultures. Other abbreviations as in Figure 1. Figure Legend:

Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Novel Inhibitory Effect of Naloxone on Macrophage Activation and Atherosclerosis Formation in Mice J Am Coll Cardiol. 2006;48(9): doi: /j.jacc Effect of naloxone treatment on LPS-induced macrophage production of superoxide. The THP-1 cell culture was pretreated for 1 h with the indicated concentrations of naloxone before stimulation with 100 ng/ml LPS. Production of superoxide in THP-1 cell culture was measured by lucigenin-enhanced chemiluminescence. Data are expressed as the mean values ± SD of 3 experiments. *p < 0.05 compared with the LPS-treated cultures. RLU = relative light units; other abbreviations as in Figure 1. Figure Legend:

Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Novel Inhibitory Effect of Naloxone on Macrophage Activation and Atherosclerosis Formation in Mice J Am Coll Cardiol. 2006;48(9): doi: /j.jacc Effect of naloxone treatment on the plasma levels of TNF-α (A) and the pulmonary inflammatory cell infiltration (B) in mice. (A) Mice were pretreated with the indicated dose of naloxone (n = 8 in 10 mg/kg, n = 7 in 20 mg/kg, and n = 5 in 25 mg/kg naloxone) or PBS (n = 7) before stimulation with LPS. Plasma TNF-α levels were measured by enzyme-linked immunosorbent assay. Data are expressed as mean values ± SD. *p < 0.05; **p < 0.01 compared with the LPS-treated only group (n = 9). (B) Mice were pretreated with the indicated dose of naloxone (n = 5 in 10 mg/kg, n = 6 in 20 mg/kg, and n = 5 in 25 mg/kg naloxone) or PBS (n = 9) before stimulation with LPS. The presence of inflammatory cells in lungs was determined by immunofluorescence. Data are expressed as the mean values ± SD. **p < 0.01 compared with the LPS-treated only group (n = 7). Other abbreviations as in Figure 1. Figure Legend:

Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Novel Inhibitory Effect of Naloxone on Macrophage Activation and Atherosclerosis Formation in Mice J Am Coll Cardiol. 2006;48(9): doi: /j.jacc Superoxide formation in the mouse aorta evaluated by oxidative fluorescent microtopography with the oxidative fluorescent dye dihydroethidium (DHE). Representative photomicrographs of the aortic sections in mice receiving lipopolysaccharide (LPS) (A), 20 mg/kg naloxone pretreatment 1 h before LPS (B), and phosphate-buffered saline (C) are shown. Increased superoxide production was visualized by amplified red fluorescence in the aortic wall after LPS stimulation (A). In comparison, staining was much more reduced in the aorta of animals receiving naloxone pretreatment (B) (bar = 50 μm). Figure Legend:

Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Novel Inhibitory Effect of Naloxone on Macrophage Activation and Atherosclerosis Formation in Mice J Am Coll Cardiol. 2006;48(9): doi: /j.jacc Influence of naloxone treatment on the plasma levels of cholesterol (A), triglycerides (B), low-density lipoprotein (LDL) (C), and high-density lipoprotein (HDL) (D). Apolipoprotein-E–deficient mice received an IP injection of 10 mg/kg/day (n = 8), 20 mg/kg/day (n = 7), or 25 mg/kg/day (n = 5) naloxone, or phosphate-buffered saline (n = 8) for 10 weeks. The results are expressed as mean values ± SD. Figure Legend:

Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Novel Inhibitory Effect of Naloxone on Macrophage Activation and Atherosclerosis Formation in Mice J Am Coll Cardiol. 2006;48(9): doi: /j.jacc Influence of naloxone treatment on atherosclerotic lesion formation in apolipoprotein-E (apoE)-deficient mice (A). The lipid-rich atherosclerotic lesions were identified with Oil-Red-O staining. Lesion area (%) was expressed as percentage of atherosclerotic area/total area of the aorta (B). The apoE-deficient mice received an IP injection of phosphate-buffered saline (PBS) (n = 8), 10 mg/kg/day (n = 8), 20 mg/kg/day (n = 7), or 25 mg/kg/day (n = 5) naloxone for 10 weeks. The results are expressed as mean values ± SD. **p < 0.01; ***p < compared with the control substance. Figure Legend:

Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Novel Inhibitory Effect of Naloxone on Macrophage Activation and Atherosclerosis Formation in Mice J Am Coll Cardiol. 2006;48(9): doi: /j.jacc (A) Representative photomicrographs of hematoxylin-eosin staining of arterial sections 28 days after carotid ligation in mice receiving naloxone (right panel) or phosphate-buffered saline (PBS) injection (left panel). Arrows indicate borders of the neointima and media. Original magnification 200×. (B) Morphometric analysis of the lumen, neointima, media, and total vascular areas. Values are mean ± SD of 5 sections in each mouse. *p < 0.05; **p < 0.01; ***p < compared with the mice receiving PBS injection. (C) Degree of neointima formation 28 days after carotid ligation was calculated according to neointima/media area (N/M) ratio. ***p < compared with the mice receiving PBS injection (bar = 100 μm). Figure Legend: